Issue link: http://osercommunicationsgroup.uberflip.com/i/1013201
Chain Drugstore Daily Saturday, August 25, 2018 6 0 in patients who don't take them." The dilemma remains: how do phar- macies contribute to increasing patient adherence in an efficient manner that does not send costs through the roof? Pharmacies have relied heavily on auto- mated patient communications, including inbound IVR, outbound notifications, web/mobile applications, MedSync and scheduling solutions for immunizations and screenings. However, employing multiple vendors can cause confusion for patients, additional work for pharmacy staff and the potential for violations of the FCC TCPA and FTC TSR regulations. MarkeTouch Media is the only provider offering turnkey patient com- munication solutions developed and managed 100 percent in-house. All serv- ices are developed and maintained by MarkeTouch employees within the United States, and it does not utilize third-party contractors. The benefits of using MarkeTouch's RxTouch suite of services include: one interface for all data transmissions, reliable security protocols across all communication channels, a sin- gle portal that allows pharmacy staff to view all patient communication and reporting through one URL, consistent messaging to patients without duplica- tion and a dedicated account manager for MarkeTouch (Cont'd. from p. 1) all questions and concerns. In addition to providing consistent messaging through automation, pharma- cies are increasing personal communica- tion between staff and patients. In its annual report card, NCPA determined that "the leading indicator of whether a patient will adhere to their medication is their personal relationship with the phar- macist or pharmacy staff." MarkeTouch's unique service, Pharmacist Connect, allows pharmacy staff to increase patient communication without affecting work- flow. A pharmacy staff member logs in to the portal (the same, single portal used for automated messaging), views patient history, medications, adherence informa- tion and potential interventions and makes calls without dialing the phone. The service has proven to increase patient adherence to their medication regimens; results include reducing return to stock by as much as 52 percent, increasing PDC scores by 5 percent, more than 50 percent MedSync enroll- ment and 25 percent real-time refills. It's clear that a single source for all patient communications increases phar- macy revenue, efficiency, patient adher- ence and satisfaction. For more information, visit booth #509, or go to www.rxtouch.com or www .marketouchmedia.com. and 95 percent symptom improvement seen at one minute and lasting up to eight hours. In fact, the strong safety profile, as shown in clinical trials of LUMIFY helped enable the new drug application (NDA) to be approved directly as an over-the-counter product as opposed to the traditional "prescription-first" route seen with most new over-the-counter drugs; an unusual occurrence in the world of over-the-counter product approvals. "The early success we're seeing with LUMIFY is due in part from the exten- sive research our team conducted with consumers," said Sharon Meckes, LUMIFY Launch Lead, Bausch + Lomb. "Through in-depth research, we sought to understand how to develop the product's unique market positioning and under- stand our lead target consumer; those who appreciate the opportunity to reduce redness to help their eyes appear more naturally radiant." In order to establish this new brand in the marketplace, Bausch + Lomb launched a substantial national media campaign inclusive of the innovative use of social media and influencers. The Bausch + Lomb (Cont'd. from p. 1) brand has also been working closely with retailers to support the launch. "Our retail partnerships have been extremely critical to launch," said Todd LaRue, Vice President, Retail Sales, Bausch + Lomb. "Together with our retail partners we have implemented cut- ting edge digital, influencer and social shopper marketing campaigns, and gar- nered significant in-line and off-shelf dis- play support. We believe these efforts, which are the basis of our in-store strate- gy, will help capture our target audience where we know they are shopping." Even though it's still early, initial results look promising. "In its first eight weeks on-shelf, LUMIFY has already become the No. 1 doctor recommended and No. 3 best-selling brand of redness reliever eye drops," said Chris Marschall, Vice President, Marketing, Consumer Healthcare, Bausch + Lomb. "LUMIFY is a truly innovative product, providing users almost an immediate visible bene- fit. With the significant investment we're putting behind the launch, we believe LUMIFY will become a must-have prod- uct for many people who are looking to reduce redness and have their eyes look whiter, brighter, more radiant." For more information, visit booth #829. the new Amneal? RS: One of our greatest strengths is our people. I am very impressed by their capability and can-do attitude. The team's passion and commitment to deliv- ering quality, service and value has enabled us to build and maintain deep customer relationships, which we will continue to strengthen. Our collective knowledge and expertise has also built a deep product portfolio and one of the most robust pipelines I've seen. Together, we are energized about the opportunity we have to evolve and strengthen our company to be an even more valued part- ner in 'making healthy possible.' CDD: How does your experience serve you in this role at Amneal and at this tur- bulent time in the industry? RS: With significant buyer consolida- tion, market dynamics are different today than over the past decade. As a result, we are ensuring that as we integrate our company, we focus on new ways to strengthen our capabilities, allocate our resources and deliver value. I bring sig- nificant experience in helping companies challenge themselves to become stronger, nimbler and more capable. These characteristics will be important for companies like ours so we remain a relevant and important partner for our customers. CDD: What is your primary focus? RS: My immediate focus remains on Amneal (Cont'd. from p. 1) seamlessly integrating the Amneal and Impax businesses, ensuring that we strengthen our valuable business rela- tionships, enhance customer confidence without disrupting supply and maintain a relentless focus on delivering the service and product launches our customers expect. No matter how much we grow or evolve, I want to make absolutely sure that we always stay customer and patient centric. CDD: What comes next? RS: Mid-term, my goals include ensur- ing we continue to deliver the right prod- ucts to market, focusing on high-barrier, complex products that deliver value to customers. Longer term, my goal is to continue diversifying our model with an expanded product offering that could include more specialty branded drugs, injectables and biosimilars as well as niche OTC portfo- lios. The beauty is that we already have the structure to support all of these areas. CDD: What do you think makes Amneal unique? RS: What I've found at Amneal is a per- formance-driven, values-focused culture with superb infrastructure. Now we must deliver on our pipeline strategies and evolve Amneal to the next chapter. I'm very excited about what's ahead, because I'm tremendously impressed with what's here right now. For more information, visit booth #110, go to www.amneal.com, call 866.525.7270 or email sales@amneal.com. Discover Cafection's Fresh Coffee Solution Introducing the most advanced fresh bean to cup coffee machines. Yes, your convenience store coffee can be like a high-end coffee shop without the barista. An affordable and reliable brewer that not only makes the best coffee you've ever tasted from a machine, but opens the door to POS solutions. The New Encore Series From Cafection Whether you have a tight space or need large format cups, Cafection has the machine for you. The Encore Series and its four new bean to cup models can brew the best possible drink while offering the best price to increase your beverage mar- gins. Those all-in-one coffee machines include enhanced functionalities such as an improved and simplified interface, customization options and online man- agement through a secure and reliable 3G cellular network. The Encore Series machines offer a choice of close to a hundred sizes and strengths recipe combinations: coffee, hot chocolate, cappuccino and more! You can even use your machine to promote another product in the store using the integrated printer system, a great cross promotion tool that will help you control your sales. Meet Sophia, the Best Partner of Your Success Developed by Cafection, Sophia— Global Management System is a web- based application offering optimized fea- tures and management possibilities for you to reduce service calls and to offer excellence, cup after cup. From service maintenance to promotion and preven- tion, Sophia offers a myriad of possibili- ties for you to bring your c- store to the next level. Push Videos on the Screen Yes, you can control your media content through Sophia—Global Management System, a completely secure and easy to control platform. Sophia is the ideal solution for internal communication, advertising and cross promo- tion, making it easy to man- age, schedule and deliver videos. It is also a great tool for your data analysis. Push videos on your brewer's touch screen and use that video time to promote your c-store, daily specials or anything else to attract your customers! More Than 20 Years of Experience Cafection boasts more than 20 years of manufacturing experience and installed its high quality coffee brewers in more than 80 percent of the Fortune 500. Every day, the com- pany works to build the greatest coffee experience, starting with fresh beans perfectly ground using the highest quality burr grinder and brewed through a French press design. Cafection is proud that more than 80,000 of its units are serving more than 2 billion cups of fresh coffee per year. Chances are that you have already tried one. When you look at what's in your store, are you satisfied with your coffee quality? Contact Cafection to learn more about its new Encore Series brewers and take the right step in making your coffee the talk of the town. For more information, call 800.561.6162 or go to www.cafection.com.